---
figid: PMC7915460__cancers-13-00700-g002
figlink: pmc/articles/PMC7915460/figure/cancers-13-00700-f002/
number: Figure 2
caption: EphA2 signaling in normal (A) and cancer (B) cells. (A) In untransformed
  cells, EphA2 is engaged by its ligands, mainly EphrinA1 and highly tyrosine-phosphorylated.
  This mediates cell adhesion/repulsion through activation of Rac/Rho GTPAses and
  RASGap. Ligand binding also mediates inhibition of MAPK and AKT. Upon ligand binding,
  the EphA2 is targeted to endosomes in a CBL-mediated process. (B) In cancer cells,
  unliganded and overexpressed EphA2 is mainly phosphorylated in ser897 by PI3k/AKT,
  ERK/RSK, PKA, and PKC, in response to oncogenic stimuli The Akt-mTORC1, Raf-MEK-ERK,
  and Pyk2-Src-ERK signaling pathways were identified as the downstream signaling
  of the EphA2 non-canonical pathway. S897-phosphorylated EphA2 recruits Ephexin4
  that in turn acts on RhoG to promote cell migration and anoikis resistance (this
  latter effect through a RhoG-AKT pathway). Further, FAK-integrin mediates cell adhesion
  and migration and may promote CSC features, including drug resistance (please also
  see Figure 3). The phospho-tyrosine content of EphA2 is also reduced by the LMW-PTPase,
  frequently overexpressed in cancer. The pro-tumorigenic contribution of EphA2 may
  thus derive from ligand independency, overexpression, reduced phospho-tyrosine content,
  and increased serine/threonine phosphorylation. Additionally, ligand-stimulated
  EphA2 negatively modulates the recycling of EGFR, by inhibiting AKT/PIKfyve, thus
  reducing the amount of available EGFR on the plasma membrane and migration. On the
  other hand, such feedback is attenuated in transformed cells, where EGFR levels
  in the plasma membrane are increased and this correlates with ligand independency
  of EphA2 and activation of motile responses to EGF.
pmcid: PMC7915460
papertitle: 'EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive
  Biomarker of Response to Anti-EGFR Agents?.'
reftext: Mario Cioce, et al. Cancers (Basel). 2021 Feb;13(4):700.
pmc_ranked_result_index: '6349'
pathway_score: 0.8651842
filename: cancers-13-00700-g002.jpg
figtitle: EphA2 signaling in normal (A) and cancer (B) cells
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7915460__cancers-13-00700-g002.html
  '@type': Dataset
  description: EphA2 signaling in normal (A) and cancer (B) cells. (A) In untransformed
    cells, EphA2 is engaged by its ligands, mainly EphrinA1 and highly tyrosine-phosphorylated.
    This mediates cell adhesion/repulsion through activation of Rac/Rho GTPAses and
    RASGap. Ligand binding also mediates inhibition of MAPK and AKT. Upon ligand binding,
    the EphA2 is targeted to endosomes in a CBL-mediated process. (B) In cancer cells,
    unliganded and overexpressed EphA2 is mainly phosphorylated in ser897 by PI3k/AKT,
    ERK/RSK, PKA, and PKC, in response to oncogenic stimuli The Akt-mTORC1, Raf-MEK-ERK,
    and Pyk2-Src-ERK signaling pathways were identified as the downstream signaling
    of the EphA2 non-canonical pathway. S897-phosphorylated EphA2 recruits Ephexin4
    that in turn acts on RhoG to promote cell migration and anoikis resistance (this
    latter effect through a RhoG-AKT pathway). Further, FAK-integrin mediates cell
    adhesion and migration and may promote CSC features, including drug resistance
    (please also see Figure 3). The phospho-tyrosine content of EphA2 is also reduced
    by the LMW-PTPase, frequently overexpressed in cancer. The pro-tumorigenic contribution
    of EphA2 may thus derive from ligand independency, overexpression, reduced phospho-tyrosine
    content, and increased serine/threonine phosphorylation. Additionally, ligand-stimulated
    EphA2 negatively modulates the recycling of EGFR, by inhibiting AKT/PIKfyve, thus
    reducing the amount of available EGFR on the plasma membrane and migration. On
    the other hand, such feedback is attenuated in transformed cells, where EGFR levels
    in the plasma membrane are increased and this correlates with ligand independency
    of EphA2 and activation of motile responses to EGF.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EPHA2
  - EGFR
  - CDH1
  - SRC
  - MAPK3
  - MAPK1
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MAK
  - RPS6KA1
  - RPS6KA3
  - RPS6KB1
  - RPS6KB2
  - RPS6KA5
  - RPS6KA6
  - RPS6KA2
  - RPS6KA4
  - RHOG
  - RAC1
  - RAC2
  - RAC3
  - RHOD
  - ACP1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - CDC42
  - PTK2
  - AKT2
  - AKT3
  - AKT1
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - CBL
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - PTK2B
  - MAP2K1
  - MAP2K2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - PLK1
genes:
- word: EPHA2
  symbol: EPHA2
  source: hgnc_symbol
  hgnc_symbol: EPHA2
  entrez: '1969'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: Rac/Rho
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: Rac/Rho
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Rac/Rho
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac/Rho
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: Rac/Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: Rac/RhoGTPASE
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: Rac/RhoGTPASE
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Rac/RhoGTPASE
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac/RhoGTPASE
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: LMW-PTP
  symbol: LMW-PTP
  source: hgnc_alias_symbol
  hgnc_symbol: ACP1
  entrez: '52'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Cdc42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: RhoG
  symbol: RhoG
  source: hgnc_alias_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: CBL
  symbol: CBL
  source: hgnc_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PYK2
  symbol: PYK2
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PIK
  symbol: PLK
  source: hgnc_prev_symbol
  hgnc_symbol: PLK1
  entrez: '5347'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases: []
---
